Atlas Trials

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Clinical trial NCT05660642 · RECRUITING

Trial details

NCT number
NCT05660642
Sponsor
Beckley Psytech Limited
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Depression
Start date
2023-02-10
Primary completion
2026-11-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.